Pacira BioSciences cut to Hold from Buy by Truist
Truist Securities downgraded Pacira BioSciences to Hold from Buy, according to Benzinga.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Truist Securities downgraded Pacira BioSciences to Hold from Buy, according to Benzinga.
TD Bank Group received regulatory approval for a new share buyback program of up to C$10 billion of common shares.